Condition
    Strong Evidence
    Effectiveness 4/5

    Lactobacillus Rhamnosus for Frequent Diarrhea

    Lactobacillus rhamnosus GG reduces the risk of antibiotic-associated diarrhea and modestly shortens acute infectious diarrhea in children, though two large North American trials found no benefit in emergency-department gastroenteritis.

    Overview

    Lactobacillus rhamnosus GG is the most heavily studied probiotic strain in diarrhoeal illness, and the evidence splits cleanly by context. For preventing antibiotic-associated diarrhoea it performs consistently well. For shortening acute infectious gastroenteritis the picture is less flattering after two large, well-conducted trials found no benefit. That split is the single most useful thing to know before buying it: the reason you are taking it determines how much to expect.
    For recurrent or frequent loose stools without a diagnosed cause, LGG is a low-risk trial rather than a treatment. Persistent diarrhoea lasting more than two weeks, or accompanied by blood, fever or weight loss, warrants investigation for infection, inflammatory bowel disease, coeliac disease or bile acid malabsorption before it is managed with supplements. Where it fits best is a defined, time-limited window: alongside and just after an antibiotic course, or during travel.

    How It Works

    LGG carries pili that let it adhere to intestinal mucus, giving it unusually good transient colonisation. While attached it competes with pathogens for binding sites and nutrients, a straightforward exclusion effect that explains much of its prophylactic value. It also secretes soluble proteins p40 and p75, which activate epithelial survival signalling and reinforce tight junctions, reducing the permeability that accompanies mucosal injury.
    Fermentation products lower luminal pH and inhibit growth of several enteric pathogens, while lactate and short-chain fatty acids feed colonocytes and support sodium and water reabsorption. These mechanisms are protective rather than curative, which is consistent with the clinical pattern: LGG reduces the chance that diarrhoea starts more reliably than it shortens diarrhoea that is already underway.

    Dosing & Protocol

    Trials used 10 to 20 billion CFU per day, typically split into two doses. Prevention studies started the probiotic on the same day as the antibiotic and continued for one to two weeks after the course finished. Dose it at least two hours away from the antibiotic itself, and keep going past the last antibiotic tablet, since the microbiome disturbance outlasts the drug.

    Fluids first

    In acute diarrhoea, oral rehydration solution does more than any probiotic. Treat LGG as an adjunct, never as the primary measure.

    Evidence

    The linked evidence includes a 2015 meta-analysis in Alimentary Pharmacology and Therapeutics supporting LGG for prevention of antibiotic-associated diarrhoea, a 2019 meta-analysis reporting a modest reduction in duration of acute paediatric diarrhoea, and the 2018 New England Journal of Medicine randomised trial that found no benefit over placebo in children with acute gastroenteritis. The NEJM trial is the highest-quality single study in the set and is the main reason the verdict is likely rather than strong.

    Studies linked to this pairing.

    Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults

    Score: 9/10
    2015
    meta_analysis
    n=1499

    Szajewska H, Kolodziej M

    LGG reduced the risk of antibiotic-associated diarrhoea from 22.4% to 12.3% (RR 0.49).

    View source

    Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis

    Score: 8/10
    2019
    meta_analysis
    n=4073

    Li YT, Xu H, Ye JZ

    LGG significantly reduced the duration of acute diarrhoea in children, with greater effect at doses of 10^10 CFU/day or more.

    View source

    Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children

    Score: 10/10
    2018
    rct
    n=971

    Schnadower D, Tarr PI, Casper TC +3 more

    Among preschool children with acute gastroenteritis, L. rhamnosus GG did not prevent development of moderate-to-severe gastroenteritis within 14 days.

    View source

    Safety

    LGG has one of the longest safety records of any probiotic and is well tolerated across age groups, including infants. Mild gas or bloating in the first days is the usual complaint. Serious events are confined to vulnerable groups. Case reports of LGG bacteraemia and endocarditis involve people with central lines, prosthetic valves, short bowel syndrome, severe immunosuppression or critical illness.

    Avoid in critical illness and immunosuppression

    Do not use live probiotics with central venous catheters, neutropenia, transplant immunosuppression or in intensive care without specialist approval.

    Interactions & Conflicts

    No metabolic drug interactions are established. The practical conflicts are antibiotic co-administration, which kills a proportion of the dose, and anti-diarrhoeal drugs such as loperamide, which can mask a bacterial or inflammatory cause that needs treating. If diarrhoea follows recent antibiotics and is severe or accompanied by fever, Clostridioides difficile should be excluded rather than self-managed.
    Interacts withSeverityMechanismAction
    moderate
    		——
    moderate
    		——
    high
    		——
    high
    		——

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.